| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/04/2010 | WO2010014812A2 Peptide compositions and methods of use |
| 02/04/2010 | WO2010014784A2 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| 02/04/2010 | WO2010014751A2 Monoclonal antibody zt/2f2 in targeted therapy of cancers overexpressing the ron receptor tyrosine kinase |
| 02/04/2010 | WO2010014595A2 Methods and compositions for delivering therapeutic agents in the treatment of b-cell related disorders |
| 02/04/2010 | WO2010014304A1 Compositions and methods related to staphylococcal bacterium proteins |
| 02/04/2010 | WO2010013601A1 Microneedle device and method for increasing the response of japanese encephalitis virus antigen with the microneedle device |
| 02/04/2010 | WO2010013498A1 Therapeutic agent or preventive agent for osteoarthritis |
| 02/04/2010 | WO2010013485A1 Melk epitope peptides and vaccines containing the same |
| 02/04/2010 | WO2010013350A1 S/o type transdermal immunizing agent |
| 02/04/2010 | WO2010012912A2 Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation |
| 02/04/2010 | WO2010012911A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs |
| 02/04/2010 | WO2010012780A1 Vaccine against hpv |
| 02/04/2010 | WO2010012495A1 Active immunisation against gip |
| 02/04/2010 | WO2010012069A1 Multivalent vaccines based on papaya mosaic virus and uses thereof |
| 02/04/2010 | WO2010012045A1 Influenza vaccines |
| 02/04/2010 | WO2009126355A3 Methods of increasing recombinant production of bacillus anthracis protective antigen |
| 02/04/2010 | WO2009115917A3 Improvements in preparation of influenza virus vaccine antigens |
| 02/04/2010 | WO2009068649A3 Antigen-binding constructs |
| 02/04/2010 | WO2009019260A3 Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage |
| 02/04/2010 | WO2003076575A9 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof |
| 02/04/2010 | WO2003072064A9 Methods and compositions for regulating adipogenesis |
| 02/04/2010 | WO2003063798A9 Compositions and methods for treatment of infectious and inflammatory diseases |
| 02/04/2010 | US20100031378 Novel gene disruptions, compositions and methods relating thereto |
| 02/04/2010 | US20100031377 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 02/04/2010 | US20100028970 Medium for the Production of Tiacumicin B |
| 02/04/2010 | US20100028453 Multi -functional nanoparticles partially-deposited with gold film |
| 02/04/2010 | US20100028451 Silk microspheres for encapsulation and controlled release |
| 02/04/2010 | US20100028450 Tolerogenic biodegradable artificial antigen presenting system |
| 02/04/2010 | US20100028448 Immunogenic compositions and methods of use |
| 02/04/2010 | US20100028446 Transport of drugs via the blood-brain barrier by means of apolipoproteins |
| 02/04/2010 | US20100028442 Methods of therapeutic treatment of eyes |
| 02/04/2010 | US20100028433 Immunogenic compositions comprising nanoemulsion and hepatitis b virus immunogen and methods of using the same |
| 02/04/2010 | US20100028423 multilayer film comprising layers of polyelectrolytes; antigenic polypeptide comprising surface adsorption regions covalently linked to antigenic determinant regions; parasite antigen; eliciting an immune response in a vertebrate organism; vaccines drug delivery device |
| 02/04/2010 | US20100028418 Gainac specific binding molecules and uses thereof |
| 02/04/2010 | US20100028415 Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus |
| 02/04/2010 | US20100028414 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy |
| 02/04/2010 | US20100028410 Immunogenic compositions and methods of use |
| 02/04/2010 | US20100028386 Recombinant p. falciparum merozoite protein-142 vaccine |
| 02/04/2010 | US20100028385 Treatment of excess cerumen secretion |
| 02/04/2010 | US20100028384 Yeast expressed classical swine fever virus glycoprotein e2 and use thereof |
| 02/04/2010 | US20100028383 Chemically defined stabiliser |
| 02/04/2010 | US20100028382 Lentival Vector-Based Vaccine |
| 02/04/2010 | US20100028381 Formulation for delivery of immune response modifiers |
| 02/04/2010 | US20100028380 B cell-based vaccine loaded with the ligand of natural killer t cell and antigen |
| 02/04/2010 | US20100028379 Methods of vaccine administration |
| 02/04/2010 | US20100028378 Toxin-antitoxin system and applications thereof |
| 02/04/2010 | US20100028377 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/04/2010 | US20100028375 Vlp based vaccine delivery system |
| 02/04/2010 | US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 02/04/2010 | US20100028373 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 02/04/2010 | US20100028372 Stabilization of aqueous compositions of proteins with displacement buffers |
| 02/04/2010 | US20100028371 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 02/04/2010 | US20100028370 Megalin-based delivery of therapeutic compounds to the brain and other tissues |
| 02/04/2010 | US20100028368 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof |
| 02/04/2010 | US20100028367 Sgp130/fc dimers |
| 02/04/2010 | US20100028366 Synergistic effect between a cyanogenic system and another oxidative inducing system for treating tumors |
| 02/04/2010 | US20100028365 Methods and compositions for the diagnosis and treatment of cancer |
| 02/04/2010 | US20100028364 Inhibition of sox9 function in the treatment of proteoglycan-associated pathophysiological conditions |
| 02/04/2010 | US20100028363 Methods for treating psoriasis |
| 02/04/2010 | US20100028362 Modulation of t helper cell-mediated immune responses |
| 02/04/2010 | US20100028361 Brain-derived gonadotropins and cognition |
| 02/04/2010 | US20100028360 Methods for the modulation of brain progestagen signaling in the prevention and treatment of neurological disorders and neurodegenerative diseases |
| 02/04/2010 | US20100028359 Antibodies to receptor of advanced glycation end products (rage) and uses thereof |
| 02/04/2010 | US20100028358 Compositions and Methods for Controlling Tissue Factor Signaling Specificity |
| 02/04/2010 | US20100028357 Antibodies That Specifically Bind to Abeta Oligomers and Uses Thereof |
| 02/04/2010 | US20100028356 Method of diagnosing a neurodegenerative disease |
| 02/04/2010 | US20100028355 Himf and btk in pulmonary, cardiac and inflammation disorders |
| 02/04/2010 | US20100028354 Compositions monovalent for cd28 binding and methods of use |
| 02/04/2010 | US20100028353 Anti-amyloid immunogenic compositions, methods and uses |
| 02/04/2010 | US20100028352 COMPOSITIONS AND METHODS COMPRISING GLYCYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
| 02/04/2010 | US20100028351 Anti-amyloid antibodies, compositions, methods and uses |
| 02/04/2010 | US20100028350 Preventing il-2 mediated inflammation in epithelial cells |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028348 Compositions and Methods for Inhibiting an Isoform of Human Manganese Superoxide Dismutase |
| 02/04/2010 | US20100028347 Antibodies against vascular endothelial growth factor receptor-1 |
| 02/04/2010 | US20100028346 Novel synergistic effects |
| 02/04/2010 | US20100028345 Il-17 receptor a antigen binding proteins |
| 02/04/2010 | US20100028344 Conditioned cell immunization |
| 02/04/2010 | US20100028343 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein |
| 02/04/2010 | US20100028342 Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity |
| 02/04/2010 | US20100028341 Amino acid sequences that modulate the interaction between cells of the immune system |
| 02/04/2010 | US20100028340 Antibodies against the rgm a protein and uses thereof |
| 02/04/2010 | US20100028339 Compositions including triciribine and trastuzumab and methods of use thereof |
| 02/04/2010 | US20100028338 Gimatecan (7-t-butoxyiminomethylcamptothecin) and chemotherapeutic agents |
| 02/04/2010 | US20100028337 Methods and compositions for modulating hyperstabilized c-met |
| 02/04/2010 | US20100028336 Anti-Mesothelin Antibodies |
| 02/04/2010 | US20100028335 Compositions and Methods to Treat Bone Related Disorders |
| 02/04/2010 | US20100028334 Compositions and methods to potentiate colistin activity |
| 02/04/2010 | US20100028333 Receptor for amyloid beta and uses thereof |
| 02/04/2010 | US20100028332 Antagonists of actriib and uses for increasing red blood cell levels |
| 02/04/2010 | US20100028331 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 02/04/2010 | US20100028330 Methods of upmodulating adaptive immune response using anti-pd1 antibodies |
| 02/04/2010 | US20100028329 Method for producing glycosylated indole compound and antibody against the compound |
| 02/04/2010 | US20100028328 Topical treatment for diseases of eye surface |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | US20100028326 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum |
| 02/04/2010 | US20100028297 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | US20100028256 Differential gene expression in physiological and pathological angiogenesis |
| 02/04/2010 | CA2742288A1 Multivalent vaccines based on papaya mosaic virus and uses thereof |